Cabaletta Bio, Inc.
CABA • NASDAQ • Stock Fundamentals
Cabaletta Bio, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Steven A. Nichtberger, with a market cap of $606.6M.
Market Cap$606.6M
Employees120.0
CEOSteven A. Nichtberger
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 14, 2026 · 14 days agoQ1 2026
View reportNext EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Cabaletta Bio, Inc. FAQ
Common questions about Cabaletta Bio, Inc.
Cabaletta Bio, Inc. (CABA) has a market capitalization of $606.6M and trades on NASDAQ.
Cabaletta Bio, Inc. has approximately 120 employees.